Catalent lays out $1B to buy gummy manufacturer Bettera, getting 4 factories and 500 new employees in the process
Catalent lays out $1B to buy gummy manufacturer Bettera, getting [...]
Sanofi, Regeneron’s Dupixent aces late-stage study in young children with atopic dermatitis
Sanofi, Regeneron’s Dupixent aces late-stage study in young children with [...]
Former Moderna CMO Zaks goes back to his Israeli roots, re-emerging as Teva board director
Former Moderna CMO Zaks goes back to his Israeli roots, [...]
ESC 2021: Bayer and Merck’s Verquvo stakes its claim as a complementary heart failure treatment
ESC 2021: Bayer and Merck’s Verquvo stakes its claim as [...]
ESC 2021: With ESC’s new heart failure endorsement, AstraZeneca’s blockbuster Farxiga is flying high
ESC 2021: With ESC’s new heart failure endorsement, AstraZeneca’s blockbuster [...]
Roche pulls Tecentriq breast cancer nod after post-approval trial flop
Roche pulls Tecentriq breast cancer nod after post-approval trial flop [...]
ESC 2021: Bayer’s Kerendia touts outcomes data as it looks to complement J&J, AZ drugs
ESC 2021: Bayer’s Kerendia touts outcomes data as it looks [...]
In talc case, reorg ruling goes J&J’s way, keeping bankruptcy in play
In talc case, reorg ruling goes J&J’s way, keeping bankruptcy [...]
In talc case, reorg ruling goes Johnson & Johnson’s way, keeping bankruptcy in play
In talc case, reorg ruling goes Johnson & Johnson’s way, [...]
BioMarin’s dwarfism drug Voxzogo scores European nod for young children, awaits looming FDA decision
BioMarin’s dwarfism drug Voxzogo scores European nod for young children, [...]